Injunctions can be decisive in life sciences patent litigation, particularly in fast-moving markets. This session delivers a strategic overview of recent developments in preliminary injunctions across the UPC, Europe, and the United States, helping patent holders and challengers alike prepare for high-stakes enforcement in 2025. With a cross-border perspective, expert speakers will unpack emerging trends, legal thresholds, and jurisdictional contrasts shaping the availability and strength of injunctive relief.
• Explore the latest PI case law from the UPC, key EU countries, and the USA and how it impacts pharma and biotech strategies.
• Understand practical approaches for securing or resisting injunctions in different jurisdictions, including timing, evidence, and risk assessment.
• Gain actionable insights on how PI outcomes are influencing broader litigation and market entry planning in the life sciences.
Kristin Cooklin
Michal Porubsky
